Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Development of R7BP inhibitors through cross-linking coupled mass spectrometry and integrated modeling.

Adikaram PR, Zhang JH, Kittock CM, Pandey M, Hassan SA, Lue NG, Wang G, Gucek M, Simonds WF.

Commun Biol. 2019 Sep 13;2:338. doi: 10.1038/s42003-019-0585-1. eCollection 2019.

2.

Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1.

Jhawar S, Lakhotia R, Suzuki M, Welch J, Agarwal SK, Sharretts J, Merino M, Ahlman M, Blau JE, Simonds WF, Del Rivero J.

Endocrinol Diabetes Metab Case Rep. 2019 Aug 20;2019. pii: EDM190040. doi: 10.1530/EDM-19-0040. [Epub ahead of print]

3.

Retrospective study of inpatient diabetes management service, length of stay and 30-day readmission rate of patients with diabetes at a community hospital.

Mandel SR, Langan S, Mathioudakis NN, Sidhaye AR, Bashura H, Bie JY, Mackay P, Tucker C, Demidowich AP, Simonds WF, Jha S, Ebenuwa I, Kantsiper M, Howell EE, Wachter P, Golden SH, Zilbermint M.

J Community Hosp Intern Med Perspect. 2019 Apr 12;9(2):64-73. doi: 10.1080/20009666.2019.1593782. eCollection 2019 Apr.

4.

CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors.

Vocke CD, Ricketts CJ, Ball MW, Schmidt LS, Metwalli AR, Middelton LA, Killian JK, Khan J, Meltzer PS, Simonds WF, Merino MJ, Linehan WM.

Urology. 2019 Feb;124:91-97. doi: 10.1016/j.urology.2018.11.013. Epub 2018 Nov 16.

5.

High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy.

Green P, Zagzag J, Patel D, Weinstein LS, Simonds WF, Blau J, Marx S, Kebebew E, Perrier N, Nilubol N.

Surgery. 2019 Jan;165(1):124-128. doi: 10.1016/j.surg.2018.04.064. Epub 2018 Nov 7.

PMID:
30414705
6.

Frequency and consequence of the recurrent YY1 p.T372R mutation in sporadic insulinomas.

Parekh VI, Modali SD, Welch J, Simonds WF, Weinstein LS, Kebebew E, Agarwal SK.

Endocr Relat Cancer. 2018 May;25(5):L31-L35. doi: 10.1530/ERC-17-0311. Epub 2018 Feb 21. No abstract available.

7.

Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.

El Lakis M, Nockel P, Gaitanidis A, Guan B, Agarwal S, Welch J, Simonds WF, Weinstein L, Marx S, Nilubol N, Patel D, Merkel R, Tirosh A, Kebebew E.

J Am Coll Surg. 2018 May;226(5):933-938. doi: 10.1016/j.jamcollsurg.2018.01.007. Epub 2018 Mar 2.

8.

Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism.

Guan B, Welch JM, Vemulapalli M, Li Y, Ling H, Kebebew E, Simonds WF, Marx SJ, Agarwal SK.

J Endocr Soc. 2017 Mar 23;1(5):488-499. doi: 10.1210/js.2017-00043. eCollection 2017 May 1.

9.

Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.

El Lakis M, Nockel P, Guan B, Agarwal S, Welch J, Simonds WF, Marx S, Li Y, Nilubol N, Patel D, Yang L, Merkel R, Kebebew E.

Surgery. 2018 Jan;163(1):31-34. doi: 10.1016/j.surg.2017.04.027. Epub 2017 Nov 3.

10.

Genetics of Hyperparathyroidism, Including Parathyroid Cancer.

Simonds WF.

Endocrinol Metab Clin North Am. 2017 Jun;46(2):405-418. doi: 10.1016/j.ecl.2017.01.006. Epub 2017 Feb 23. Review.

11.

A central role for R7bp in the regulation of itch sensation.

Pandey M, Zhang JH, Mishra SK, Adikaram PR, Harris B, Kahler JF, Loshakov A, Sholevar R, Genis A, Kittock C, Kabat J, Ganesan S, Neubig RR, Hoon MA, Simonds WF.

Pain. 2017 May;158(5):931-944. doi: 10.1097/j.pain.0000000000000860.

12.

GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.

Guan B, Welch JM, Sapp JC, Ling H, Li Y, Johnston JJ, Kebebew E, Biesecker LG, Simonds WF, Marx SJ, Agarwal SK.

Am J Hum Genet. 2016 Nov 3;99(5):1034-1044. doi: 10.1016/j.ajhg.2016.08.018. Epub 2016 Oct 13.

13.

A patient with MEN1 typical features and MEN2-like features.

El-Maouche D, Welch J, Agarwal SK, Weinstein LS, Simonds WF, Marx SJ.

Int J Endocr Oncol. 2016 May;3(2):89-95. Epub 2016 Apr 8.

14.

GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability.

Lodder EM, De Nittis P, Koopman CD, Wiszniewski W, Moura de Souza CF, Lahrouchi N, Guex N, Napolioni V, Tessadori F, Beekman L, Nannenberg EA, Boualla L, Blom NA, de Graaff W, Kamermans M, Cocciadiferro D, Malerba N, Mandriani B, Coban Akdemir ZH, Fish RJ, Eldomery MK, Ratbi I, Wilde AAM, de Boer T, Simonds WF, Neerman-Arbez M, Sutton VR, Kok F, Lupski JR, Reymond A, Bezzina CR, Bakkers J, Merla G.

Am J Hum Genet. 2016 Sep 1;99(3):786. doi: 10.1016/j.ajhg.2016.08.011. Epub 2016 Sep 1. No abstract available.

15.

GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability.

Lodder EM, De Nittis P, Koopman CD, Wiszniewski W, Moura de Souza CF, Lahrouchi N, Guex N, Napolioni V, Tessadori F, Beekman L, Nannenberg EA, Boualla L, Blom NA, de Graaff W, Kamermans M, Cocciadiferro D, Malerba N, Mandriani B, Akdemir ZHC, Fish RJ, Eldomery MK, Ratbi I, Wilde AAM, de Boer T, Simonds WF, Neerman-Arbez M, Sutton VR, Kok F, Lupski JR, Reymond A, Bezzina CR, Bakkers J, Merla G.

Am J Hum Genet. 2016 Sep 1;99(3):704-710. doi: 10.1016/j.ajhg.2016.06.025. Epub 2016 Aug 11. Erratum in: Am J Hum Genet. 2016 Sep 1;99(3):786.

16.

Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism.

Keutgen XM, Nilubol N, Agarwal S, Welch J, Cochran C, Marx SJ, Weinstein LS, Simonds WF, Kebebew E.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):701-707. Epub 2016 Jul 27.

17.

Optimization of genome editing through CRISPR-Cas9 engineering.

Zhang JH, Adikaram P, Pandey M, Genis A, Simonds WF.

Bioengineered. 2016 Apr;7(3):166-74. doi: 10.1080/21655979.2016.1189039. Review.

18.

Endocrine neoplasms in familial syndromes of hyperparathyroidism.

Li Y, Simonds WF.

Endocr Relat Cancer. 2016 Jun;23(6):R229-47. doi: 10.1530/ERC-16-0059. Epub 2016 May 20. Review.

19.

Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure.

Nilubol N, Weinstein LS, Simonds WF, Jensen RT, Marx SJ, Kebebew E.

Ann Surg Oncol. 2016 Feb;23(2):416-23. doi: 10.1245/s10434-015-4865-9. Epub 2015 Nov 5.

PMID:
26542588
20.

Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.

Sadowski SM, Millo C, Cottle-Delisle C, Merkel R, Yang LA, Herscovitch P, Pacak K, Simonds WF, Marx SJ, Kebebew E.

J Am Coll Surg. 2015 Aug;221(2):509-17. doi: 10.1016/j.jamcollsurg.2015.04.005. Epub 2015 Apr 20.

21.

Hyperparathyroidism-jaw tumor syndrome: Results of operative management.

Mehta A, Patel D, Rosenberg A, Boufraqech M, Ellis RJ, Nilubol N, Quezado MM, Marx SJ, Simonds WF, Kebebew E.

Surgery. 2014 Dec;156(6):1315-24; discussion 1324-5. doi: 10.1016/j.surg.2014.08.004. Epub 2014 Oct 16.

22.

Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter.

Zhang JH, Pandey M, Kahler JF, Loshakov A, Harris B, Dagur PK, Mo YY, Simonds WF.

J Biotechnol. 2014 Nov 10;189:1-8. doi: 10.1016/j.jbiotec.2014.08.033. Epub 2014 Sep 2.

23.

Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.

Nilubol N, Weisbrod AB, Weinstein LS, Simonds WF, Jensen RT, Phan GQ, Hughes MS, Libutti SK, Marx S, Kebebew E.

World J Surg. 2013 Aug;37(8):1966-72. doi: 10.1007/s00268-013-2054-1.

PMID:
23722465
24.

Cerebellar abnormalities in mice lacking type 3 deiodinase and partial reversal of phenotype by deletion of thyroid hormone receptor α1.

Peeters RP, Hernandez A, Ng L, Ma M, Sharlin DS, Pandey M, Simonds WF, St Germain DL, Forrest D.

Endocrinology. 2013 Jan;154(1):550-61. doi: 10.1210/en.2012-1738. Epub 2012 Nov 16.

25.

Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.

Weisbrod AB, Nilubol N, Weinstein LS, Simonds WF, Libutti SK, Jensen RT, Marx SJ, Kebebew E.

J Clin Endocrinol Metab. 2013 Jan;98(1):E109-14. doi: 10.1210/jc.2012-2781. Epub 2012 Oct 23.

26.

Aromatase inhibitor treatment of menorrhagia and subsequent pregnancy in a patient with familial hyperparathyroidism-jaw tumor syndrome.

Wolff EF, Hill MJ, Simonds WF, Segars JH.

Fertil Steril. 2012 Dec;98(6):1616-9. doi: 10.1016/j.fertnstert.2012.08.017. Epub 2012 Sep 8.

27.

Sleeping parathyroid tumor: rapid hyperfunction after removal of the dominant tumor.

Yavuz S, Simonds WF, Weinstein LS, Collins MT, Kebebew E, Nilubol N, Phan GQ, Libutti SK, Remaley AT, Van Deventer M, Marx SJ.

J Clin Endocrinol Metab. 2012 Jun;97(6):1834-41. doi: 10.1210/jc.2011-3030. Epub 2012 Apr 16.

28.

Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?

Nilubol N, Weinstein L, Simonds WF, Jensen RT, Phan GQ, Hughes MS, Libutti SK, Marx S, Kebebew E.

World J Surg. 2012 Jun;36(6):1368-74. doi: 10.1007/s00268-012-1451-1.

PMID:
22350475
29.

Expression of the Gβ5/R7-RGS protein complex in pituitary and pancreatic islet cells.

Nini L, Zhang JH, Pandey M, Panicker LM, Simonds WF.

Endocrine. 2012 Aug;42(1):214-7. doi: 10.1007/s12020-012-9611-5. Epub 2012 Feb 10. No abstract available.

30.

A new look at vitamin D metabolism and "idiopathic" hypercalcemia.

Simonds WF.

J Clin Endocrinol Metab. 2012 Feb;97(2):384-6. doi: 10.1210/jc.2011-3405. No abstract available.

31.

The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome.

Zhang JH, Seigneur EM, Pandey M, Loshakov A, Dagur PK, Connelly PS, Koo L, Panicker LM, Simonds WF.

Cell Death Dis. 2012 Feb 2;3:266. doi: 10.1038/cddis.2012.6.

32.

Cushing's syndrome in multiple endocrine neoplasia type 1.

Simonds WF, Varghese S, Marx SJ, Nieman LK.

Clin Endocrinol (Oxf). 2012 Mar;76(3):379-86. doi: 10.1111/j.1365-2265.2011.04220.x.

33.

Knockout of G protein β5 impairs brain development and causes multiple neurologic abnormalities in mice.

Zhang JH, Pandey M, Seigneur EM, Panicker LM, Koo L, Schwartz OM, Chen W, Chen CK, Simonds WF.

J Neurochem. 2011 Nov;119(3):544-54. doi: 10.1111/j.1471-4159.2011.07457.x. Epub 2011 Sep 23.

34.

Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation.

Caron P, Simonds WF, Maiza JC, Rubin M, Cantor T, Rousseau L, Bilezikian JP, Souberbielle JC, D'Amour P.

Clin Endocrinol (Oxf). 2011 Jun;74(6):694-8. doi: 10.1111/j.1365-2265.2011.04021.x.

35.

Parathyroid cancer.

Sharretts JM, Kebebew E, Simonds WF.

Semin Oncol. 2010 Dec;37(6):580-90. doi: 10.1053/j.seminoncol.2010.10.013. Review.

36.

Clinical and molecular genetics of parathyroid neoplasms.

Sharretts JM, Simonds WF.

Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):491-502. doi: 10.1016/j.beem.2010.01.003. Review.

37.

Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73.

Zhang JH, Panicker LM, Seigneur EM, Lin L, House CD, Morgan W, Chen WC, Mehta H, Haj-Ali M, Yu ZX, Simonds WF.

Cell Death Differ. 2010 Oct;17(10):1551-65. doi: 10.1038/cdd.2010.32. Epub 2010 Mar 26.

38.

Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome.

Panicker LM, Zhang JH, Dagur PK, Gastinger MJ, Simonds WF.

Endocr Relat Cancer. 2010 May 18;17(2):513-24. doi: 10.1677/ERC-09-0272. Print 2010 Jun.

39.

Nuclear localization of the G protein beta 5/R7-regulator of G protein signaling protein complex is dependent on R7 binding protein.

Panicker LM, Zhang JH, Posokhova E, Gastinger MJ, Martemyanov KA, Simonds WF.

J Neurochem. 2010 Jun;113(5):1101-12. doi: 10.1111/j.1471-4159.2010.06616.x. Epub 2010 Jan 22.

40.

Reoperation for parathyroid adenoma: a contemporary experience.

Powell AC, Alexander HR, Chang R, Marx SJ, Skarulis M, Pingpank JF, Bartlett DL, Hughes M, Weinstein LS, Simonds WF, Collins MF, Shawker T, Chen CC, Reynolds J, Cochran C, Steinberg SM, Libutti SK.

Surgery. 2009 Dec;146(6):1144-55. doi: 10.1016/j.surg.2009.09.015.

41.

The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene.

Lin L, Zhang JH, Panicker LM, Simonds WF.

Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17420-5. doi: 10.1073/pnas.0710725105. Epub 2008 Nov 5.

42.

The parafibromin tumor suppressor protein interacts with actin-binding proteins actinin-2 and actinin-3.

Agarwal SK, Simonds WF, Marx SJ.

Mol Cancer. 2008 Aug 7;7:65. doi: 10.1186/1476-4598-7-65.

43.
44.

Ruling out a suspect: the role of beta-catenin mutation in benign parathyroid neoplasia.

Simonds WF.

J Clin Endocrinol Metab. 2007 Apr;92(4):1235-6. No abstract available.

PMID:
17409343
46.

The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.

Ozawa A, Agarwal SK, Mateo CM, Burns AL, Rice TS, Kennedy PA, Quigley CM, Simonds WF, Weinstein LS, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ.

J Clin Endocrinol Metab. 2007 May;92(5):1948-51. Epub 2007 Feb 13.

PMID:
17299066
47.

Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.

Kelly TG, Shattuck TM, Reyes-Mugica M, Stewart AF, Simonds WF, Udelsman R, Arnold A, Carpenter TO.

J Bone Miner Res. 2006 Oct;21(10):1666-71.

48.

Editorial: Imaging to detect early endocrine cancers.

Marx SJ, Simonds WF.

J Clin Endocrinol Metab. 2006 Aug;91(8):2861-3. No abstract available.

PMID:
16894022
49.

Adenylyl cyclase type-VIII activity is regulated by G(betagamma) subunits.

Steiner D, Saya D, Schallmach E, Simonds WF, Vogel Z.

Cell Signal. 2006 Jan;18(1):62-8. Epub 2005 May 31.

PMID:
15925485
50.

Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.

Pidasheva S, Canaff L, Simonds WF, Marx SJ, Hendy GN.

Hum Mol Genet. 2005 Jun 15;14(12):1679-90. Epub 2005 May 6.

PMID:
15879434

Supplemental Content

Loading ...
Support Center